Series B - X4 Pharmaceuticals - Nov 16, 2017 Funding Round Profile - Cointime

Bitcoin $99,277.57 +1.94%
Ethereum $3,379.59 +7.81%
BNB $629.47 +2.79%
Optimism $2.06 +19.96%
Arbitrum $0.79 +12.14%
Solana $260.26 +8.22%
Polygon $0.46 +5.02%
Cosmos $6.58 +5.61%
Avalanche $36.10 +6.10%

Bitcoin $99,277.57 +1.94%
Ethereum $3,379.59 +7.81%
BNB $629.47 +2.79%
Optimism $2.06 +19.96%
Arbitrum $0.79 +12.14%
Solana $260.26 +8.22%
Polygon $0.46 +5.02%
Cosmos $6.58 +5.61%
Avalanche $36.10 +6.10%

X4 Pharmaceuticals

company

Funding Round

Series B

Money Raised

$ 27M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Cormorant Asset Management	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Dec 15, 2015	Series A	$ 37.49M	Cormorant Asset Management	Detail
Jan 1, 2014	Seed	0	SV Health Investors	Detail